Jubilant DraxImage is dedicated to providing radiopharmaceuticals for the diagnosis and treatment of a variety of diseases. We invite you to learn more about these areas and how our products are used by healthcare professionals to care for their patients.
Jubilant DraxImage Inc. (a wholly-owned subsidiary of Jubilant Pharma) is a Nuclear Medicine company that develops, manufactures and commercializes radiopharmaceuticals used for the diagnosis, treatment and monitoring of disease.
Jubilant DraxImage, based in Montreal Canada, has 160 highly skilled employees that provide quality radiopharmaceutical products in 21 different countries around the globe.
Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to our customers across geographies. We organise our business into two segments, namely, Specialty Pharmaceuticals, comprising Radiopharmaceuticals (including Radiopharmacies), Contract Manufacturing of Sterile Injectables and Non-sterile Products and Allergy Therapy Products, and Generics & APIs, comprising Solid Dosage Formulations and Active Pharmaceutical Ingredients.
We supply our products and services to customers in over 85 countries. We have four manufacturing facilities in North America and two in India, coupled with Research and Development centers in North America and India. In addition, we have a distribution network of more than 50 radiopharmacies in the United States.
Allergy Therapy Products
One of the top three players with a market share of 17.6% in the allergenic extract market in the United States and are currently the sole producer and supplier of venom products for the treatment of allergies in the United States.
Solid Dosage Formulations
One of the market leaders in the United States, based on market share of several key products